PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Announces Investment in Spine BioPharma

20 апр 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

14 апр 2021 15:00:00 Источник Nasdaq GlobeNewswire

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

07 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

22 мар 2021 17:42:22 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

09 мар 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

03 мар 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

25 фев 2021 07:00:03 Источник Nasdaq GlobeNewswire

Pacira to Report 2020 Financial Results on Thursday February 25, 2021

18 фев 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021

10 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics

26 янв 2021 07:00:01 Источник Nasdaq GlobeNewswire